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Senior Consultant Cardiologist, Moolchand Medcity, New Delhi, IndiaA scenario not infrequently encountered in our practice is
given below. A 45-year-old normotensive and non-diabetic
male shopkeeper had chest and upper abdominal pain
beginning early in the morning. The pain initially was inter-
mittent and temporarily subsided. Our patient attributed the
discomfort to upper gastro-intestinal discomfort and he had
some home remedies for gastric discomfort. Four hours later,
after reaching his workplace, the pain increased and was
associated with vomiting. He contacted local general practi-
tioner, who evaluated him and administered injectable ranit-
idine and antiemetics. There was temporary improvement
and he went back to his home. On the way home, he had an
episode of fainting and was rushed to the hospital in the
nearby town which was 40 km away. He was admitted and
found to have extensive ST Elevation anterior wall myocardial
infarction (STEMI) with qRBBB. He was thrombolysed with
streptokinase with a window period of 14 h. He seemed to be
stable. Later in the night, the patient developed acute pulmo-
nary edema and required intravenous diuretics, nitroglycerine
andmorphine. Next daymorning the patient was referred to a
PCI capable centre, which was 50 km away. He underwent an
angiogram that showed an occluded proximal left anterior
descending artery and an ejection fraction of 20e25%. He un-
derwent rescue PCI and stenting to proximal LAD with non
medicated stent. The procedure was complicated by no flow
and hypotension, for which adjunctive pharmacotherapy
along with intra-aortic balloon pump were used. He remained
in CCU for 7 days and was later discharged with an ejection
fraction of 20e25%. The patient was discharged on multiple
medications. One month after his acute MI, the patient
continued to have class III dyspnea with exertion and was
unable to return to work. A follow-up echocardiogram
demonstrated impaired left ventricular systolic function (EF
25%) with severe apical hypokinesis. He was advised an
implantable cardiac defibrillator, which he could not afford.E-mail address: drhkchopra@gmail.com.
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0019-4832/Copyright © 2015, Cardiological Society of India. All rightsThe above scenario is fairly frequently seen by Indian
cardiologists even in 2015. The case brings out glaring de-
ficiencies at various levels in STEMI care in India. Individu-
ally, we have excellent hospitals, physicians, clinical
cardiologists, and cardiac interventionists. Of late we are
having good ambulance services, at least in some states.
However, we do not have ANY system in place for STEMI care
across the country. The world-over dedicated STEMI pro-
grams are successfully implemented in many Western
countries for nearly three decades. This commentary focuses
on the possible systems that may be put in place to improve
the acute care of STEMI across India. Most of the improve-
ment in outcomes in Indian patients could be achieved by
timely implementation of the proven therapies focusing the
time window.1. Problems in STEMI care in India
Indian ACS patients, for reasons not exactly clear, seem to
present with higher percentage of STEMI. They are less likely
to receive timely reperfusion therapy, invasive therapy and
evidence based medicines.1e3 The above patient scenario
brings forth a few major lacunae in STEMI care that include
lack of dedicated STEMI care systems, lack of instantaneously
available ECG facility at first point of medical contact, lack of
patient awareness, lack of physician readiness, lack of
equipped ambulance systems network for patient transport
(Emergency Cardiac Services: ECS) and pay from pocket for
even Emergency Medical Services (EMS). These are the major
reasons for the excess mortality and poorer outcomes seen in
Indian patients with STEMI.3
In a registry involving 50 cities, only 58.5% of patients with
STEMI were thrombolysed mostly with streptokinase and a
minority received percutaneous coronary intervention (PCI).reserved.
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inmost parts of India is likely to lower as these registries have
sampled data from tertiary care centres and some of the better
developed states. The reported 30-day outcomes for patients
with STEMI in the Create registry were death (8.6%), rein-
farction (2.3%), and stroke (0.7%).3 Mortality benefits of PPCI
lost if it is delayed more than 60 min as depicted in the Global
Registry of Acute Coronary Event.4 Importantly, the poor are
marginalized in STEMI care and are less likely to receive
thrombolytics, percutaneous coronary intervention and even
lipid-lowering drugs. Consequently, the mortality was also
higher for poor patients.5
In the Italian Registry of TNK in STEMI of 27,000 patients.6
It has been shown the thrombolysis with TNK is easily n,
accessible, and available everywhere. Door to balloon time
in PPCI exceeds 90 min practically. Then, PPCI does not
reduce mortality consistently. Rapid diagnosis and early
reperfusion are pillars of success in STEMI Care. TNK is
Class 1A recommendation for STEMI ACCP Guideline7 and is
recommended in Pre- Hospital Thrombolysis Protocol
(Vienna STEMI Registry8 The Mayo Clinic STEMI Protocol9
and The French FAST-MI registry10). The potential of TNK
cannot be overemphasized. It is given a bolus dose with no
hypertension, no allergic reactions, longer half life, high
fibrin specificity and simplified weight adjusted dose, with
mostly very minor manageable bleeding. It is an agent of
first choice for pre-hospital thrombolysis in STEMI. It has
been shown in one of the study that only 4% of transferred
patients received PPCI within 90 min.11 Pre-hospital throm-
bolysis is the strongest independent predictor of in-hospital
survivor in UK.12
In the recently published Indian registry on STEMI con-
sisting of 15,222 patients 722 centres treated with indigenous
tenecteplase (TNK) has shown clinically successful throm-
bolysis in 96.5% of patients in less than 3 h, 96% in three to 6 h
and 85.3% in more than 6 h of STEMI.13 Pharmaco invasive
therapy including early administration of thrombolysis (TNK)
followed by PCI within 3e24 h after initiation of thrombolytic
therapy regardless of success of thrombolysis. However in
case of thrombolytic failure, a rescue PCI should be instanta-
neously performed. Timely guided protocol for early throm-
bolysis with tenecteplase (Grade IA) at the level of physician,
non-PCI capable centres/nursing homes with intensive care
facility and subsequent access to PCI capable centres im-
proves STEMI outcome.14 Such a strategymay be the preferred
strategy in India as PPCI possible only in 10% of STEMI
patients.142. STEMI care in India: barriers and
prospects
There are significant barriers to effective STEMI care. They are
at public awareness level, patient level, hospital/physician
level and at Government and societal levels. Patients often
ignore symptoms, self medicate and evenwhen they decide to
seek medical attention, they consult non-physicians in India.
To overcome these barriers, organized patient education and
awareness programs are urgently needed. Cardiological soci-
ety of India (CSI), Association of physicians of India (API) andthe Indian medical association (IMA) should join hands in
these awareness programs. Such programs should not only
use the traditional methods like public lectures, print mate-
rials, but should also focus on television, internet and social
media. The public should be educated that for anyone beyond
their teens, an ECG is amust for acute pain or discomfort from
jaw to umbilicus including upper limbs. Public should be
educated about the significance of time, seeking immediate
medical attention and timely reaching the ‘right’ hospital or
physician for STEMI care.
Another most important barrier is at the level of hospital
systems. For a country like India,wherein only less than 10%of
STEMI patients receive PCI, primary PCI cannot andwill not be
the answer for every patient of STEMI. We should rely on
thrombolysis, especially bolus agents like Tenecteplase (TNK),
and promptly shifting the patients to a PCI capable centre.
Considering the efficacy, a strategy of prehospital thrombol-
ysis should be ideally suited for Indian conditions. Considering
the diverse Indian conditions, a combination of strategies
could bemore appropriate. For instance, primary PCI should be
the preferred strategy inmost of the hospitals,who are already
offering 24  7 emergency PCI services and the patient can
reach the available STEMI Care PPCI capable centres less than
90 min.15 In case there is a delay in access to PPCI capable
centre due to lack of transfer facility, densely populated cities,
traffic congestions etc. Other cities and small district towns
would have certified STEMI care physicians and hospitals.
These hospitals should do the initial care, thrombolysis with
TNK, management of complications and then should have an
organized way of early transfer to nearby cities wherein early
angiogram and PCI are possible. For rest of rural India, pre-
hospital thrombolysis with TNK could be the ideal strategy.
For these to become practical, we need to have “Integrated
STEMI Care Systems”. We need to have emergency (108) am-
bulances, equippedwith a facility to do an ECG and transmit to
a central station, wherein a cardiologist can ascertain STEMI.
Uponconfirmationof STEMI, thepatient should receiveaspirin
and statin. These ambulances should also have medical and
paramedical personnel who can assess sickness, administer a
questionnaire to assess the suitability for thrombolysis with
TNK. The patient should be taken in the ambulance that has
facility to monitor rhythm and defibrillator. Automated algo-
rithms can decide, based on the place, distance to an STEMI
hospital or a PCI capable centre, whether to shift for primary
PCI or to a hospital for thrombolysis or pre-hospital throm-
bolysis in the ambulance itself. Accordingly the hospital
should be activated and no time should be wasted at the hos-
pital emergency. If pre-hospital thrombolysis is decided, the
patient or relativemay talk to a centrally stationed cardiologist
and the medical personnel get a consent and administer the
agent under cardiac monitoring inside the ambulance, while
the patient is being shifted to a nearby hospital.
The above ambitious plan could only work if there is
governmental participation and the STEMI care is integrated
to the existing emergency care systems in India. The govern-
ment should make emergency STEMI treatment at subsidized
cost to all Indians, may be through medical insurance
schemes. The Government should identify STEMI care centres
in each city, district and rural areas and certify them. The
information on the list of PCI capable and other STEMI care
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should also ensure the availability of thrombolytic, especially
bolus agents like TNK at subsidized cost to the poor. Recently
published STREAM Trial 2014 with 1 year mortality follow up
data has shown that PPCI less than 60 min is not practical in
most of the STEMI patients, thus, TNK followed by PCI in 24 h
is strongly recommended protocol.16
Therefore, Golden time window intervention of <2 h is
most powerful predictor of salvaging jeopardized myocar-
dium in STEMI and significantly reduce STEMI inflicted
morbidity and mortality. If TNK is given in <60 min, it may
reduce infarct size from larger to smaller, transmural to sub-
endocardial or may even abort MI, thus help improving sub-
sequent PCI outcome by reducing thrombus burden and better
TIMI flow. Time delay>90min reduce the benefit of PPCI. Thus
the objective of Integrated TIMI Care is to minimize time from
chest discomfort to ECG <30 min (FMC), ECG to drug inter-
vention <60 min, drug intervention to PCI <90e120 min will
definitely have STEMI inflicted morbidity and mortality
benefit in our country to create global impact. We must act
locally to impact globally.r e f e r e n c e s
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